Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives
Elisabetta Degasperi, Alessio AghemoDivision of Gastroenterology and Hepatology, AM and M Migliavacca Center, Fondazione IRCCS Ca' Granda Maggiore Hospital, University of Milan, Milan, ItalyAbstract: In recent years, clinical research in the field of new treatments for chronic hepatitis C (...
Guardado en:
Autores principales: | Degasperi E, Aghemo A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d4444966b31d429fb2606060cfb123db |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Decreasing racial disparity with the combination of ledipasvir–sofosbuvir for the treatment of chronic hepatitis C
por: Naylor PH, et al.
Publicado: (2017) -
Interferon-free combination therapies for the treatment of hepatitis C: current insights
por: Holmes JA, et al.
Publicado: (2015) -
Hepatitis C in Argentina: epidemiology and treatment
por: Gaite LA, et al.
Publicado: (2014) -
Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
por: Sundaram V, et al.
Publicado: (2016) -
Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
por: Lim TR
Publicado: (2014)